Clark M. Hatheway

693 citations
4 papers · 483 indexed · 1 hit paper · h-index 2
Topics
Neuroblastoma Research and Treatments (2 papers)Protein Degradation and Inhibitors (2 papers)Cancer-related Molecular Pathways (1 paper)
Partner nations
United States

In The Last Decade

Clark M. Hatheway

4 papers receiving 477 citations

Hit Papers

CDK7 Inhibition Suppresses Super-Enhancer-Linked Oncogeni...20142026201820222014100200300400

Peers

Clark M. Hatheway
Comparison fields: 5 of 40
  • Molecular Biology 405
  • Oncology 152
  • Neurology 69
  • Pulmonary and Respiratory Medicine 65
  • Cancer Research 57
Replace Abigail Altabef with:
Abigail Altabef United States
Robyn T. Sussman United States
Edward Favours United States
Bandana Sharma United States
Dailia B. Francis United States
Annika Sprüssel Germany
F Kaye United States
Rachel Ingraham United States
Jessie Hao-Ru Hsu United States
N C Cheng Netherlands
Clark M. Hatheway relative to Abigail Altabef United States Abigail Altabef's profile →
Citations per field
00.5×1.5×
Abigail Altabef · 1×
Citations per year

Countries citing papers authored by Clark M. Hatheway

Since Specialization
Citations

This map shows the geographic impact of Clark M. Hatheway's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Clark M. Hatheway with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Clark M. Hatheway more than expected).

Fields of papers citing papers by Clark M. Hatheway

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Clark M. Hatheway. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Clark M. Hatheway. The network helps show where Clark M. Hatheway may publish in the future.

Co-authorship network of co-authors of Clark M. Hatheway

This figure shows the co-authorship network connecting the top 25 collaborators of Clark M. Hatheway. A scholar is included among the top collaborators of Clark M. Hatheway based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Clark M. Hatheway. Clark M. Hatheway is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

4 of 4 papers shown
#WorkIndexed citations
1 1
2
CDK7 Inhibition Suppresses Super-Enhancer-Linked Oncogenic Transcription in MYCN-Driven Cancer
1
3
CDK7 Inhibition Suppresses Super-Enhancer-Linked Oncogenic Transcription in MYCN-Driven Cancerbreakdown →
451
4 30

About Clark M. Hatheway

Clark M. Hatheway is a scholar working on Urology, Neurology and Obstetrics and Gynecology, having authored 4 papers that have together received 483 indexed citations. Recurring topics across this work include Neuroblastoma Research and Treatments (2 papers), Protein Degradation and Inhibitors (2 papers) and Cancer-related Molecular Pathways (1 paper). The work is most often cited by research in Molecular Biology (405 citations), Oncology (152 citations) and Neurology (69 citations). Clark M. Hatheway has collaborated with scholars based in United States. Frequent co-authors include Caleb M. Yeung, Nicholas Kwiatkowski, Bandana Sharma, Kwok‐Kin Wong, Edmond Chipumuro, Brian J. Abraham, Camilla L. Christensen, Guo‐Cheng Yuan, Nathanael S. Gray and Antonio R. Pérez‐Atayde. Their work appears in journals such as Cell, Molecular Pharmacology and Journal of Pediatric Urology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026